Exelon and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Exelon (rivastigmine tartrate), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Memantine Hydrochloride, and have High blood pressure.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Exelon. It is created by eHealthMe based on reports of 10,864 people who have side effects when taking Exelon from the FDA, and is updated regularly.

What is Exelon?

Exelon has active ingredients of rivastigmine tartrate. It is often used in alzheimer's disease. eHealthMe is studying from 11,060 Exelon users. Check the latest studies of Exelon.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,492 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

10,864 people reported to have side effects when taking Exelon.
Among them, 11 people (0.1%) have Visual acuity reduced.

Could Exelon cause Visual acuity reduced?

Among these 11 people:

How long have people been on Exelon when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Exelon? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Visual acuity reduced when taking Exelon? *

What are other drugs people take besides Exelon? *

Cialis: 2 people, 18.18%
Doxazosin Mesylate: 2 people, 18.18%
Micardis: 2 people, 18.18%
Memantine Hydrochloride: 2 people, 18.18%
Zymar: 1 person, 9.09%
Lasix: 1 person, 9.09%
Amlodipine: 1 person, 9.09%
Atacand: 1 person, 9.09%
Avastin: 1 person, 9.09%
Benicar: 1 person, 9.09%

What are other side effects people have besides Visual acuity reduced? *

Vision Blurred: 4 people, 36.36%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 3 people, 27.27%
Weakness: 2 people, 18.18%
Retinal Disorder (disease of retina): 2 people, 18.18%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 2 people, 18.18%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 18.18%
Blindness: 2 people, 18.18%
Arrhythmias (irregular heartbeat): 2 people, 18.18%
Blood Potassium Decreased: 1 person, 9.09%
Confusion: 1 person, 9.09%

What are the existing conditions these people have? *

Memory Loss: 4 people, 36.36%
High Blood Pressure: 4 people, 36.36%
Thyroid Diseases: 3 people, 27.27%
Erection Problems: 2 people, 18.18%
Prostatic Disorder: 2 people, 18.18%
Parkinson's Disease: 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Retinal Oedema (swelling of retina): 1 person, 9.09%
High Blood Cholesterol: 1 person, 9.09%
Sodium Retention: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Exelon and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exelon:

Exelon (11,060 reports)

Browse all side effects of Exelon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,492 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate (the active ingredients of Exelon) and Exelon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.